Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
A hospital emergency room. Photo: Dennis M. Rivera Pichardo/The Washington Post via Getty Images
Emergency rooms are facing severe shortages of commonly used drugs, in part because of problems at Pfizer plants, The New York Times reports.
Details: Shortages of pain medications like morphine are especially severe.
- Pfizer is the country's largest manufacturer of generic injectable drugs, and these shortages have gotten worse as the Food and Drug Administration uncovered serious safety concerns at multiple Pfizer facilities.
- The FDA has loosened some of its restrictions in the face of growing shortages, allowing Pfizer to sell some products that normally would have to be recalled.
The issue: These drugs' low profit margins are part of the reason more companies don't manufacture them, FDA Commissioner Scott Gottlieb told the Times.
- “We are still in the position of trying to put a Band-Aid on a market that fundamentally hasn’t changed,” he said. “Today it’s one drug, tomorrow is going to be another drug. We’ve got to think of something more holistic and comprehensive.”